Calidi Biotherapeutics, Inc. (CLDI) SEC Filings & Financial Intelligence
Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLDI
CIK: 1855485
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerSougata Banerjee
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-25 | 2026-09-21 | 8-K | 0001493152-26-044381 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-17 | 8-K | 0001493152-26-043724 | View SEC Doc Filr Page |
| 424B5 | 2026-09-17 | — | 424B5 | 0001493152-26-043156 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039292 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039290 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039291 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039289 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039288 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039287 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039286 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039285 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003562 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037847 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037840 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-27 | 8-K | 0001493152-26-035666 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-10 | 8-K | 0001493152-26-033594 | View SEC Doc Filr Page |
| 3 | 2026-06-29 | 2026-06-17 | 3 | 0001493152-26-031118 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-17 | 8-K | 0001493152-26-029710 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-12 | 8-K | 0001493152-26-029374 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-05 | — | DEFA14A | 0001493152-26-027516 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-28 | 8-K | 0001493152-26-026415 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002136 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023140 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001493152-26-023094 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-06 | 8-K | 0001493152-26-022024 | View SEC Doc Filr Page |